Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.
Clinical trial NCT03272425 · COMPLETED
Trial details
- NCT number
- NCT03272425
- Sponsor
- Ardea Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2017-10-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.